Washington, D.C. On January 31, 2020, officials of the governments of Canada and the United States convened in Washington, D.C. at the White House Office of National Drug Control Policy to move forward with a bilateral initiative to find solutions to the opioid crisis affecting both nations. When Prime Minister Justin Trudeau and President Donald […]

February 5, 2020

Canada’s acting Ambassador to the United States, Kirsten Hillman, issued the following statement today following an announcement by the U.S. Administration to issue a notice of proposed rulemaking that, if finalized, would allow for the importation of certain prescription drugs from Canada: “We recognize that the debate about the importation of prescription drugs to the […]

December 18, 2019

  Related Products Readout of Acting Ambassador Kirsten Hillman’s Meeting with Joe Grogan, Assistant to the President for Domestic Policy Lowering U.S. Prescription Drug Prices Requires a Made-in-the-USA Solution

December 2, 2019

Canada’s acting Ambassador to the United States, Kirsten Hillman, issued the following statement today following her meeting with Joe Grogan, Assistant to the President for Domestic Policy, regarding the Administration’s proposed Safe Importation Action Plan.  On October 22, Ms. Hillman had a similar meeting with John Brooks, Senior Advisor for Drug Pricing Reform and other […]

November 1, 2019